| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 03/31/2004 | EP1401269A2 Transgenic animal model of bone mass modulation |
| 03/31/2004 | EP1248519A4 Expansion of stem and progenitor cells by beta-catenin |
| 03/31/2004 | EP1181318B1 Monoclonal antibodies, synthetic and biotechnological derivatives thereof acting as ngf-antagonist molecules |
| 03/31/2004 | EP1012256B1 Recombinant fusion proteins based on ribosome-inactivating proteins of european mistletoe viscum album |
| 03/31/2004 | EP1003863B1 Mammalian cytokine receptor-11 |
| 03/31/2004 | EP0935652B1 Keratinocyte growth factor-2 products |
| 03/31/2004 | EP0866860B1 Novel tyrosine kinase receptors and ligands |
| 03/31/2004 | EP0852011B1 ANTIBODIES SPECIFIC FOR NATIVE PrP?Sc |
| 03/31/2004 | EP0742833B1 Recombinant baculovirus and use thereof in the production of monoclonal antibodies |
| 03/31/2004 | EP0735818B1 MACROPHAGE INFLAMMATORY PROTEINS MIP-3, MIP-4 AND MIP-1gamma |
| 03/31/2004 | EP0731806B1 SPECIFIC FUSION NUCLEIC ACIDS AND PROTEINS PRESENT IN HUMAN t(2;5) LYMPHOMA, METHODS OF DETECTION AND USES THEREOF |
| 03/31/2004 | EP0710253B1 Antibodies specific for human prostate glandular kallikrein |
| 03/31/2004 | EP0681477B1 Genetic modification of neural stem cells |
| 03/31/2004 | EP0666916B1 Plasmodium falciparum antigens inducing protective antibodies |
| 03/31/2004 | EP0656948B1 Bordetella bronchiseptica vaccine |
| 03/31/2004 | CN1486368A Methods for the production of multimeric proteins, and related compositions |
| 03/31/2004 | CN1486365A Expression of xenogenous (human) immunoglobulins in cloned, transgenic ungulates |
| 03/31/2004 | CN1486328A Method for surface display of proteins on genetic carriers |
| 03/31/2004 | CN1486327A 载脂蛋白类似物 Apolipoprotein analogues |
| 03/31/2004 | CN1486192A Binding domain-immunoglobulin fusion proteins |
| 03/31/2004 | CN1485433A Process for preparing chicken colibacillus pilus monoclonal antibody |
| 03/31/2004 | CN1485432A Exhibiting method of preparing antibody by antigen utilizing bacteriophage exhibiting technique |
| 03/31/2004 | CN1485340A Polypeptide-human transmembrane glycopeptide 25 and polynucleotide for encoding such polypeptide |
| 03/31/2004 | CN1485339A Polypeptide-human zinc finger protein 70 and polynucleotide for coding this polypeptide |
| 03/31/2004 | CN1485338A Polypeptide -Human vacuole carrier protein 13 and polynucleotide for encoding this polypeptide |
| 03/31/2004 | CN1485337A Polypeptide-human actin heavy chain 74 and polynucleotide for coding this polypeptide |
| 03/31/2004 | CN1485336A Polypeptide- human clathrin 82 and polynucleotide for coding such polypeptide |
| 03/31/2004 | CN1485335A Polypeptide-embryonic development protien 65 and polynucleotide for coding this polypeptide |
| 03/31/2004 | CN1485334A Polypeptide-human I complement receptor protein 222 and polynucleotide for coding such polypeptide |
| 03/31/2004 | CN1485333A Polypeptide-human X linked gene espression protein 14 and polynucleotide for encoding such polypeptide |
| 03/31/2004 | CN1485332A Polypeptide-human ª‰transducin 72 and polynucleotide for coding the same |
| 03/31/2004 | CN1143895C Gene engineering process for preparing diad/triad fusion protein of erythrocyte growth factor with improved bioactivity |
| 03/30/2004 | US6713621 Chimeric compositions having multi-modalities are also provided which can affect a plurality of gene functions by interfering with splicing or translation as well as transcription |
| 03/30/2004 | US6713611 Removing endotoxin from a basic protein; obtain solution containing basic protein, expose to detergent, expose to column, wash, elute basic protein from column |
| 03/30/2004 | US6713609 Monoclonal antibodies to type I interferon receptor |
| 03/30/2004 | US6713607 Effector proteins of Rapamycin |
| 03/30/2004 | US6713606 Conjugates of soluble peptidic compounds with membrane-binding agents |
| 03/30/2004 | US6713450 Synthetic immunogenic but non-amyloidogenic peptides homologous to amyloid β for induction of an immune response to amyloid β and amyloid deposits |
| 03/30/2004 | US6713281 Directed evolution of thermophilic enzymes |
| 03/30/2004 | US6713276 Modulation of Aβ levels by β-secretase BACE2 |
| 03/30/2004 | US6713272 Attachment of biomolecules to hydrophobic surfaces |
| 03/30/2004 | US6713270 Dna encoding a novel steroid receptor is introduced into cell with reporter gene, potential ligand is incubated with cell, production of reporter protein means ligand binds receptor |
| 03/30/2004 | US6713266 Immunoassay method for measuring a cyclosporine and its metabolites |
| 03/30/2004 | US6713249 Soild supports for use in monitoring osteogenesis |
| 03/30/2004 | CA2235471C Dna encoding a plasminogen activating protein |
| 03/30/2004 | CA2136103C Antibiotic cryptdin peptides and methods of their use |
| 03/25/2004 | WO2004025416A2 Bioinformatic method for identifying surface-anchored proteins from gram-positive bacteria and proteins obtained thereby |
| 03/25/2004 | WO2004025264A2 Rapidly degraded reporter fusion proteins |
| 03/25/2004 | WO2004025256A2 Viral deconstruction through capsid assembly in vitro |
| 03/25/2004 | WO2004024927A1 Protein production method |
| 03/25/2004 | WO2004024913A1 Novel proteins and dnas encoding the same |
| 03/25/2004 | WO2004024909A2 Recombinant colstridium neurotoxin fragments |
| 03/25/2004 | WO2004024764A1 Pharmaceutical composition and medical treatments comprising notch ligand proteins |
| 03/25/2004 | WO2004024748A2 High affinity monoclonal antibody for recognizing the progesterone receptor (pr) and method for creating the antibody |
| 03/25/2004 | WO2004024747A2 High affinity monoclonal antibody for recognizing the estrogen receptor (er) and method for creating the antibody |
| 03/25/2004 | WO2004024097A2 Compositions and methods for the treatment of immune related diseases |
| 03/25/2004 | WO2004024088A2 Design of chemokine analogs for the treatment of human diseases |
| 03/25/2004 | WO2004024077A2 Novel composition and methods for the treatment of psoriasis |
| 03/25/2004 | WO2004024076A2 Novel compositions and methods for the treatment of immune related diseases |
| 03/25/2004 | WO2004024068A2 Novel composition and methods for the treatment of immune related diseases |
| 03/25/2004 | WO2004024064A2 Compositions and methods for the diagnosis and treatment of tumor |
| 03/25/2004 | WO2004024063A2 Compositions and methods for the diagnosis and treatment of tumor |
| 03/25/2004 | WO2004008100A3 Methods and media for controlling sialylation of proteins produced by mammalian cells |
| 03/25/2004 | WO2003100001A3 Claudin polypeptides, polynucleotides, and methods of making and use thereof |
| 03/25/2004 | WO2003092610A3 Methods of using cytokine antagonists to treat hiv infection and aids |
| 03/25/2004 | WO2003085375A3 Hcv antiviral and cytotoxicity drug screening assay |
| 03/25/2004 | WO2003077844A3 Effect of treatment with 4,5-dihydroxy- 2-cyclopenten-1-one (dhcp) on gene expression and quorum-sensing in bacteria |
| 03/25/2004 | WO2003074546A3 Streptavidin-binding peptide |
| 03/25/2004 | WO2003054156A3 Novel g proein-coupled receptor, gave7 |
| 03/25/2004 | WO2003051923A3 Novel g-protein coupled receptors and dna sequences thereof |
| 03/25/2004 | WO2003044210A3 Process for preparing insulin compounds |
| 03/25/2004 | WO2003033680A3 Kinases and phosphatases |
| 03/25/2004 | WO2003031475A3 Antibodies against kdr, their production and uses |
| 03/25/2004 | WO2003020215A3 Methods of treating mycocardial event related coditions with thymosin beta 4 |
| 03/25/2004 | WO2003010186A3 Method for making acylated polypeptides |
| 03/25/2004 | WO2003010185A3 Method for making acylated polypeptides |
| 03/25/2004 | WO2002102829A3 Cross-reactive monoclonal and polyclonal antibodies which recognize surface proteins from coagulase-negative staphylococci and staphylococcus aureus |
| 03/25/2004 | WO2002096942A3 Recombinant dna encoding the major allergen of plantago lanceolata pollen pla l 1, and applications thereof |
| 03/25/2004 | WO2002094855A3 Peptide synthesis method |
| 03/25/2004 | WO2002083859A8 Surface proteins of streptococcus pyogenes |
| 03/25/2004 | WO2002072832A3 Therapeutic binding molecules |
| 03/25/2004 | WO2002063006A3 Receptors and membrane-associated proteins |
| 03/25/2004 | US20040060079 Method of controlling character of monocotyledon by modification and/or overexpression of cytochrome P450 monooxygenase gene involved in brassinosteroid biosynthesis and monocotyledon modified by the gene |
| 03/25/2004 | US20040059096 Immunoglobulin for preventing shellfish poisoning |
| 03/25/2004 | US20040059091 Protein complexes and process for producing the same |
| 03/25/2004 | US20040058866 Method for preparing tryptophan rich peptides |
| 03/25/2004 | US20040058860 Novel bacillus thuringiensis isolate active against lepidopteran pests, and genes encoding novel lepidopteran-active toxins |
| 03/25/2004 | US20040058443 Manipulation of non-terminally differentiated cells using the Notch pathway |
| 03/25/2004 | US20040058424 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/25/2004 | US20040058415 Preparing modified/artificial polypeptides; mimetics |
| 03/25/2004 | US20040058414 Preparing antibody capable of binding and inhibiting activity of interleukin-2 and receptor, herpes viral epitopes and interferon receptors; diagnosis and treatment of viral and autoimmune diseases |
| 03/25/2004 | US20040058413 Method for the production of vitamin k-dependent proteins |
| 03/25/2004 | US20040058411 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/25/2004 | US20040058402 Method for purifying the helicobacter adhesin-like protein a (alpa) |
| 03/25/2004 | US20040058371 Novel natural antibacterial peptide, the nucleotide sequence encoding it and the use thereof |
| 03/25/2004 | US20040058366 Comprises DNA coding brain-muscle-arnt-like protein 2 (BMAL2) for diagnosis and treatment of circadian rythm disorders |
| 03/25/2004 | US20040058362 Polymerase chimeras |
| 03/25/2004 | US20040058358 Lipid metabolism transcription factor |
| 03/25/2004 | US20040058355 Comprises nucleotide sequences coding membrane proteins for diagnosis and treatment of brain, breast disorders, colon, kidney, inflammatory, brain and urogenital disorders |
| 03/25/2004 | US20040058351 Method of examining for allergic disease |